Effects of quercetin and extracts from Phyllanthus emblica, Morus alba, and Ginkgo biloba on platelet recovery in a rat model of chemotherapy-induced thrombocytopenia

Kriangkrai Chawansuntati; Sayamon Hongjaisee; Kittichai Sirita; Kornkamon Kingkaew; Kritsadee Rattanathammethee; Benjawan Kumrapich; Sakaewan Ounjaijean; Aphisek Kongkaew; Nongkran Lumjuan

doi:10.1016/j.heliyon.2024.e25013

Effects of quercetin and extracts from Phyllanthus emblica, Morus alba, and Ginkgo biloba on platelet recovery in a rat model of chemotherapy-induced thrombocytopenia

Heliyon. 2024 Jan 19;10(2):e25013. doi: 10.1016/j.heliyon.2024.e25013. eCollection 2024 Jan 30.

Authors

Kriangkrai Chawansuntati¹, Sayamon Hongjaisee¹, Kittichai Sirita¹, Kornkamon Kingkaew¹, Kritsadee Rattanathammethee¹, Benjawan Kumrapich¹, Sakaewan Ounjaijean¹, Aphisek Kongkaew², Nongkran Lumjuan¹

Affiliations

¹ Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, 50200, Thailand.
² Research Administration Section, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

Abstract

Background: Chemotherapy-induced thrombocytopenia (CIT) is a major reason for chemotherapy delays, dose reduction, or even treatment discontinuation, which may impact oncologic outcomes. We investigated the effects of quercetin and extracts of Phyllanthus emblica fruit (PEE), Morus alba leaf (MAE), and Ginkgo biloba leaf (GBE) on platelet recovery in a rat model of chemotherapy-induced thrombocytopenia.

Methods: The total phenolic content (TPC), total flavonoid content (TFC), quercetin content, and antioxidant activities of all the extracts were determined. Sixty male Sprague Dawley rats were categorized into healthy controls and CIT groups. The CIT groups was administered a cyclophosphamide solution, while the control group received a saline solution. Each group was then subdivided into five subgroups of six animals which were administered with PEE, MAE, GBE, quercetin, or a vehicle for 15 days.

Results: The highest quercetin content was found in PEE, followed by MAE and GBE, which correlated with their antioxidant properties. Administration of these extracts and quercetin did not significantly change the platelet counts in healthy rats. Thrombocytopenic rats treated with PEE, MAE, and GBE also were not associated with significant changes in platelet counts. However, more rapid platelet count recovery was observed in all groups receiving extracts. On day 11, platelet counts in the PEE, MAE, and GBE groups returned to near baseline levels with a mean of 4.29 %, -40.77 %, and -14.24 %, respectively, compared to -71 % in the CIT group. In thrombocytopenic rats treated with quercetin, there was a significant increase in platelet counts on days 9 and 11, with a mean decrease of 5.41 % from baseline on day 11.

Conclusion: Quercetin improved platelet recovery in the animal model of CIT. This finding merits for further investigation to better elucidate the health benefits of quercetin and quercetin-rich plants and potential pharmacokinetics underpinning their activity in thrombocytopenia.

Keywords: Ginkgo biloba; Morus alba; Phyllanthus emblica; Platelet; Quercetin; Thrombocytopenia.